BOLT vs PH · rev $7.7M vs P/E 28, rev $19.85B
Bolt Biotherapeutics (BOLT) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
BOLT currently screens at market cap $11.3M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the BOLT and PH stock pages for the full models.
Not investment advice.